Head of the Pharmacology Department

• Sep 2016 - Present

Assist Prof Dr Assist Prof Dr

Management Committee Member and working group member in WG2, WG4 and WG5 in PRESTO action

• Oct 2022 - Present

P2X receptors (P2XRs) are ATP-gated ion channels involved in intercellular communication with an established role in neurodegeneration, infection, inflammation, cancer growth, and progression. In vitro and in vivo evidence, generated mainly by leading Europe-based laboratories, shows that P2XRs might be an ideal pharmacological target in these diseases and many others. CA21130 COST Action: P2X receptors as a therapeutic opportunity (PRESTO) aims at accelerating the transition of P2XRs knowledge to clinical applications.I am interested in working group-2 which focuses on P2XRs in neurodegenerative diseases and depression; WG4 and WG5 which focus on how to translate lab research into clinics.WG2-P2XRs in neurodegenerative diseases and depressionWG4-Data integration and translation to the market and the clinicsWG5-Dissemination and outreachhttps://www.p2xcost.eu/ Show less

Management Committee Member and working group leader in CONNECT action

• Oct 2020 - Present

CA19127 COST Action: Cognitive decline in Nephro-Neurology: European Cooperative Target (CONNECT) aims to coordinate research on cognitive impairment in CKD. This requires exchanging clinical information between nephrologists and neurologists, and between neuroscientists and kidney physiologists, guided by big data analysts. This collaborative network will define new experimental paradigms, their translational value and, in turn, focus on new interventions in the field of cognitive impairment.In this project, as a member of the preclinical working group (WG1) we focus on animal models of cognitive impairment and chronic kidney disease. The aim of this group is to elucidate the underlying mechanisms of cognitive impairment in CKD patients and to identify new treatment options. Besides, I am also a member of WG3, which aims to develop a common language between neurology, nephrology and pharmacology, where clinical applications are discussed. I work as the leader of the project's communication and dissemination working group. It is among the duties of WG5 to spread the results of this action to the public and the scientific community. In addition, I try to contribute to producing publications and projects in cooperation with other WGs.www.connectcost.eu Show less

Steering Committee Member in working group 1 and 4, and member of WG2 in ENABLE action

• Oct 2020 - Present

The COST Action “European Network to Advance Best practices & technoLogy on medication adherencE” (ENABLE) CA19132 aims to create a multidisciplinary network of relevant stakeholders that work collaboratively towards economically viable implementation of medication adherence enhancing technologies across different European healthcare systems.In this project, I am one of the active team members working to develop ideas about how digital health tools can improve medication adherence, present the MATech products available in Europe in detail, and ensure the communication and dissemination of the project. Stakeholder engagement at the EU level and collaboration with patient organizations are also among my interests as project management skills.www.enableadherence.eu Show less

Visiting Lecturer

• Oct 2019 - Present

Faculty of Dentistry Faculty of Dentistry

Visiting Lecturer

• Jan 2020 - Jan 2020

Erasmus Staff Mobility- 1 week • Teaching: urological pharmacology and diabetes mellitus • Observer in the laboratory for Parkinson’s Disease projects Erasmus Staff Mobility- 1 week • Teaching: urological pharmacology and diabetes mellitus • Observer in the laboratory for Parkinson’s Disease projects

Consultant

• Apr 2004 - Jul 2018

• Advisor and organiser of drug databases for electronic claim process projects and digital health • Analysing pharmacological effects of the drugs as indications, side-effects, bioavailability, equivalence • Coordinating the drug data according to international codes as ATC, NFC, ICD • Organising the drug data in order to refund systems • Advisor and organiser of drug databases for electronic claim process projects and digital health • Analysing pharmacological effects of the drugs as indications, side-effects, bioavailability, equivalence • Coordinating the drug data according to international codes as ATC, NFC, ICD • Organising the drug data in order to refund systems

Phd Pharm

• Oct 2015 - Aug 2016

Farmateam AŞ Farmateam AŞ

Postdoctoral Researcher

• Jan 2014 - Sep 2015

• ER-stress, oxidative stress in cardiomyocytes and cell lines • ER-stress, oxidative stress in cardiomyocytes and cell lines

Owner

• Jun 2005 - Dec 2013